Clinical Trial: Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Somatuline® Depot (Lanreotide) Injection for Acromegaly (SODA): A Post-marketing Observational Study

Brief Summary: To assess the safety and effectiveness of Somatuline® Depot (lanreotide) Injection when administered by a health care professional (HCP), the patient, the patient's partner or parent/guardian as part of their routine acromegaly care.